Symbols / DHR Stock $177.25 -0.74% Danaher Corporation

Healthcare • Diagnostics & Research • United States • NYQ
DHR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Rainer M. Blair
Exch · Country NYQ · United States
Market Cap 125.45B
Enterprise Value 139.44B
Income 3.68B
Sales 24.78B
FCF (ttm) 4.57B
Book/sh 74.32
Cash/sh 8.05
Employees 58,000
Insider 10d —
IPO Dec 29, 1978
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 26.36%
P/E 34.35
Forward P/E 19.49
PEG 1.13
P/S 5.06
P/B 2.39
P/C —
EV/EBITDA 17.57
EV/Sales 5.63
Quick Ratio 1.40
Current Ratio 1.87
Debt/Eq 37.17
LT Debt/Eq —
EPS (ttm) 5.16
EPS next Y 9.09
EPS Growth 9.80%
Revenue Growth 3.70%
EPS Gr Q/Q 7.90%
Rev Gr Q/Q —
Earnings (next) 2026-07-21
Earnings (prior) 2026-04-21
ROA 4.19%
ROE 7.08%
ROIC —
Gross Margin 58.99%
Oper. Margin 22.94%
Profit Margin 14.89%
Shs Outstand 707.77M
Shs Float 630.66M
Insider Own 10.78%
Instit Own 84.30%
Short Float 1.29%
Short Ratio 2.14
Short Interest 8.18M
52W High 242.80
vs 52W High -27.00%
52W Low 175.00
vs 52W Low 1.29%
Beta 0.99
Impl. Vol. 38.77%
Rel Volume 1.44
Avg Volume 4.44M
Volume 6.41M
Target (mean) $250.14
Tgt Median $247.50
Tgt Low $205.00
Tgt High $310.00
# Analysts 22
Recom Strong_buy
Prev Close $178.57
Price $177.25
Change -0.74%
About

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$250.14
Mean price target
2. Current target
$177.25
Latest analyst target
3. DCF / Fair value
$116.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$177.25
Low
$205.00
High
$310.00
Mean
$250.14

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-23 main Morgan Stanley Overweight → Overweight $255
2026-04-22 main UBS Buy → Buy $250
2026-04-22 main Wells Fargo Equal-Weight → Equal-Weight $212
2026-04-22 main Guggenheim Buy → Buy $235
2026-04-22 main Baird Outperform → Outperform $245
2026-04-17 main Baird Outperform → Outperform $249
2026-04-14 main Barclays Overweight → Overweight $230
2026-04-13 main Goldman Sachs Buy → Buy $230
2026-04-06 main Evercore ISI Group Outperform → Outperform $225
2026-01-29 main JP Morgan Overweight → Overweight $275
2026-01-29 main Jefferies Buy → Buy $265
2026-01-07 main TD Cowen Buy → Buy $270
2026-01-05 main Guggenheim Buy → Buy $275
2025-12-15 main Wells Fargo Equal-Weight → Equal-Weight $240
2025-12-09 init Goldman Sachs — → Buy $265
2025-12-02 init Morgan Stanley — → Overweight $270
2025-10-23 main Wells Fargo Equal-Weight → Equal-Weight $230
2025-10-22 main TD Cowen Buy → Buy $260
2025-10-22 main Barclays Overweight → Overweight $250
2025-10-08 down Rothschild & Co Buy → Neutral $220
News
RSS: Latest DHR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-27 RALES MITCHELL P Officer and Director — 71,648 $0.00 $0
2026-02-27 MCGREW MATTHEW Officer — 5,935 $0.00 $0
2026-02-27 BOUDA CHRISTOPHER Officer — 1,247 $0.00 $0
2026-02-27 COUCHARA GEORGEANN F. Officer — 4,748 $0.00 $0
2026-02-27 RILEY CHRISTOPHER PAUL Officer — 6,172 $0.00 $0
2026-02-27 SAWYER MONTGOMERY JULIE A Officer — 6,172 $0.00 $0
2026-02-27 MILOSEVICH GREGORY M Officer — 4,273 $0.00 $0
2026-02-27 GUGINO MATTHEW E. Chief Financial Officer — 3,988 $0.00 $0
2026-02-27 GRAY ROBERT BRADLEY Officer — 2,849 $0.00 $0
2026-02-27 LEIKEN JONATHAN B Officer — 2,374 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
24,568.00
+2.90%
23,875.00
-0.06%
23,890.00
-10.33%
26,643.00
Operating Revenue
24,568.00
+2.90%
23,875.00
-0.06%
23,890.00
-10.33%
26,643.00
Cost Of Revenue
10,045.00
+3.89%
9,669.00
-1.90%
9,856.00
-5.73%
10,455.00
Reconciled Cost Of Revenue
10,045.00
+3.89%
9,669.00
-1.90%
9,856.00
-5.73%
10,455.00
Gross Profit
14,523.00
+2.23%
14,206.00
+1.23%
14,034.00
-13.31%
16,188.00
Operating Expense
9,833.00
+5.24%
9,343.00
+5.79%
8,832.00
+2.08%
8,652.00
Research And Development
1,598.00
+0.88%
1,584.00
+5.39%
1,503.00
-1.64%
1,528.00
Selling General And Administration
8,235.00
+6.13%
7,759.00
+5.87%
7,329.00
+2.88%
7,124.00
Other Operating Expenses
—
—
—
—
Total Expenses
19,878.00
+4.56%
19,012.00
+1.73%
18,688.00
-2.19%
19,107.00
Operating Income
4,690.00
-3.56%
4,863.00
-6.52%
5,202.00
-30.97%
7,536.00
Total Operating Income As Reported
4,690.00
-3.56%
4,863.00
-6.52%
5,202.00
-30.97%
7,536.00
EBITDA
6,945.00
-4.55%
7,276.00
-2.93%
7,496.00
-20.94%
9,482.00
Normalized EBITDA
7,173.00
-2.18%
7,333.00
-4.49%
7,678.00
-21.28%
9,753.00
Reconciled Depreciation
2,447.00
+4.04%
2,352.00
+8.59%
2,166.00
+1.59%
2,132.00
EBIT
4,498.00
-8.65%
4,924.00
-7.62%
5,330.00
-27.48%
7,350.00
Total Unusual Items
-228.00
-300.00%
-57.00
+68.68%
-182.00
+32.84%
-271.00
Total Unusual Items Excluding Goodwill
-228.00
-300.00%
-57.00
+68.68%
-182.00
+32.84%
-271.00
Special Income Charges
20.00
0.00
0.00
0.00
Other Special Charges
—
—
—
—
Write Off
—
—
108.00
+18.68%
91.00
Net Income
3,614.00
-7.31%
3,899.00
-18.16%
4,764.00
-33.92%
7,209.00
Pretax Income
4,233.00
-8.89%
4,646.00
-7.89%
5,044.00
-29.42%
7,146.00
Net Non Operating Interest Income Expense
-235.00
-45.96%
-161.00
-1047.06%
17.00
+110.43%
-163.00
Interest Expense Non Operating
265.00
-4.68%
278.00
-2.80%
286.00
+40.20%
204.00
Net Interest Income
-235.00
-45.96%
-161.00
-1047.06%
17.00
+110.43%
-163.00
Interest Expense
265.00
-4.68%
278.00
-2.80%
286.00
+40.20%
204.00
Interest Income Non Operating
30.00
-74.36%
117.00
-61.39%
303.00
+639.02%
41.00
Interest Income
30.00
-74.36%
117.00
-61.39%
303.00
+639.02%
41.00
Other Income Expense
-222.00
-296.43%
-56.00
+68.00%
-175.00
+22.91%
-227.00
Other Non Operating Income Expenses
6.00
+500.00%
1.00
-85.71%
7.00
-84.09%
44.00
Gain On Sale Of Security
-248.00
-335.09%
-57.00
+68.68%
-182.00
+32.84%
-271.00
Gain On Sale Of Business
9.00
0.00
0.00
0.00
Tax Provision
633.00
-15.26%
747.00
-9.23%
823.00
+0.61%
818.00
Tax Rate For Calcs
0.00
-6.83%
0.00
-1.23%
0.00
+42.98%
0.00
Tax Effect Of Unusual Items
-34.20
-272.67%
-9.18
+69.07%
-29.67
+3.97%
-30.89
Net Income Including Noncontrolling Interests
3,614.00
-7.31%
3,899.00
-18.16%
4,764.00
-33.92%
7,209.00
Net Income From Continuing Operation Net Minority Interest
3,600.00
-7.67%
3,899.00
-7.63%
4,221.00
-33.30%
6,328.00
Net Income From Continuing And Discontinued Operation
3,614.00
-7.31%
3,899.00
-18.16%
4,764.00
-33.92%
7,209.00
Net Income Continuous Operations
3,600.00
-7.67%
3,899.00
-7.63%
4,221.00
-33.30%
6,328.00
Net Income Discontinuous Operations
14.00
0.00
-100.00%
543.00
-38.37%
881.00
Normalized Income
3,793.80
-3.88%
3,946.82
-9.75%
4,373.33
-33.42%
6,568.11
Net Income Common Stockholders
3,614.00
-7.31%
3,899.00
-17.79%
4,743.00
-33.23%
7,103.00
Diluted EPS
5.05
-4.54%
5.29
-17.08%
6.38
-33.95%
9.66
Basic EPS
5.07
-4.88%
5.33
-17.24%
6.44
-34.29%
9.80
Basic Average Shares
712.70
-2.50%
731.00
-0.75%
736.50
+1.57%
725.10
Diluted Average Shares
716.10
-2.86%
737.20
-0.79%
743.10
+0.81%
737.10
Diluted NI Availto Com Stockholders
3,614.00
-7.31%
3,899.00
-17.79%
4,743.00
-33.23%
7,103.00
Gain On Sale Of PPE
11.00
0.00
0.00
—
Preferred Stock Dividends
—
—
21.00
-80.19%
106.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
83,464.00
+7.64%
77,542.00
-8.22%
84,488.00
+0.16%
84,350.00
Current Assets
12,756.00
+34.32%
9,497.00
-31.86%
13,937.00
-12.25%
15,883.00
Cash Cash Equivalents And Short Term Investments
4,615.00
+122.09%
2,078.00
-64.56%
5,864.00
-2.19%
5,995.00
Cash And Cash Equivalents
4,615.00
+122.09%
2,078.00
-64.56%
5,864.00
-2.19%
5,995.00
Receivables
3,913.00
+10.63%
3,537.00
-9.82%
3,922.00
-4.39%
4,102.00
Accounts Receivable
3,913.00
+10.63%
3,537.00
-9.82%
3,922.00
-4.39%
4,102.00
Gross Accounts Receivable
4,027.00
+10.33%
3,650.00
-9.70%
4,042.00
-3.62%
4,194.00
Allowance For Doubtful Accounts Receivable
-114.00
-0.88%
-113.00
+5.83%
-120.00
-30.43%
-92.00
Inventory
2,489.00
+6.82%
2,330.00
-10.18%
2,594.00
-6.18%
2,765.00
Raw Materials
733.00
+1.81%
720.00
-15.59%
853.00
-13.31%
984.00
Work In Process
469.00
+0.86%
465.00
+1.31%
459.00
+8.77%
422.00
Finished Goods
1,287.00
+12.40%
1,145.00
-10.69%
1,282.00
-5.67%
1,359.00
Prepaid Assets
—
—
—
—
Assets Held For Sale Current
—
—
0.00
-100.00%
1,280.00
Other Current Assets
1,739.00
+12.05%
1,552.00
-0.32%
1,557.00
-10.57%
1,741.00
Total Non Current Assets
70,708.00
+3.91%
68,045.00
-3.55%
70,551.00
+3.04%
68,467.00
Net PPE
5,531.00
+10.84%
4,990.00
+9.60%
4,553.00
+22.76%
3,709.00
Gross PPE
10,298.00
+13.28%
9,091.00
+8.50%
8,379.00
+17.32%
7,142.00
Accumulated Depreciation
-4,767.00
-16.24%
-4,101.00
-7.19%
-3,826.00
-11.45%
-3,433.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
233.00
+1.30%
230.00
+9.52%
210.00
+4.48%
201.00
Buildings And Improvements
3,054.00
+19.86%
2,548.00
+12.30%
2,269.00
+26.41%
1,795.00
Machinery Furniture Equipment
4,867.00
+9.86%
4,430.00
+7.89%
4,106.00
+18.09%
3,477.00
Other Properties
2,144.00
+13.86%
1,883.00
+4.96%
1,794.00
+7.49%
1,669.00
Goodwill And Other Intangible Assets
60,968.00
+3.22%
59,065.00
-5.27%
62,354.00
+9.21%
57,097.00
Goodwill
43,151.00
+6.55%
40,497.00
-2.67%
41,608.00
+11.62%
37,276.00
Other Intangible Assets
17,817.00
-4.04%
18,568.00
-10.50%
20,746.00
+4.67%
19,821.00
Other Non Current Assets
4,209.00
+5.49%
3,990.00
+9.50%
3,644.00
-52.43%
7,661.00
Total Liabilities Net Minority Interest
30,923.00
+10.47%
27,992.00
-9.70%
30,998.00
-9.52%
34,260.00
Current Liabilities
6,807.00
+0.13%
6,798.00
-17.84%
8,274.00
-1.37%
8,389.00
Payables And Accrued Expenses
2,451.00
+2.30%
2,396.00
-1.11%
2,423.00
-5.05%
2,552.00
Payables
2,451.00
+2.30%
2,396.00
-1.11%
2,423.00
-5.05%
2,552.00
Accounts Payable
1,844.00
+5.19%
1,753.00
-0.74%
1,766.00
-4.85%
1,856.00
Other Payable
75.00
+0.00%
75.00
+0.00%
75.00
+0.00%
75.00
Employee Benefits
968.00
+14.02%
849.00
+6.39%
798.00
+15.65%
690.00
Pensionand Other Post Retirement Benefit Plans Current
1,247.00
+7.78%
1,157.00
-2.28%
1,184.00
-3.11%
1,222.00
Total Tax Payable
532.00
-6.34%
568.00
-2.41%
582.00
-6.28%
621.00
Current Debt And Capital Lease Obligation
201.00
-70.35%
678.00
-63.84%
1,875.00
+147.36%
758.00
Current Debt
2.00
-99.60%
505.00
-70.21%
1,695.00
+186.80%
591.00
Other Current Borrowings
2.00
-99.60%
505.00
-70.21%
1,695.00
+186.80%
591.00
Current Capital Lease Obligation
199.00
+15.03%
173.00
-3.89%
180.00
+7.78%
167.00
Current Deferred Liabilities
1,353.00
+4.16%
1,299.00
-11.33%
1,465.00
+0.62%
1,456.00
Current Deferred Revenue
1,353.00
+4.16%
1,299.00
-11.33%
1,465.00
+0.62%
1,456.00
Other Current Liabilities
1,368.00
+26.32%
1,083.00
-7.59%
1,172.00
-47.44%
2,230.00
Total Non Current Liabilities Net Minority Interest
24,116.00
+13.79%
21,194.00
-6.73%
22,724.00
-12.16%
25,871.00
Liabilities Heldfor Sale Non Current
—
—
0.00
-100.00%
287.00
Long Term Debt And Capital Lease Obligation
19,495.00
+18.38%
16,468.00
-6.75%
17,661.00
-11.06%
19,858.00
Long Term Debt
18,416.00
+18.81%
15,500.00
-7.22%
16,707.00
-12.46%
19,086.00
Long Term Capital Lease Obligation
1,079.00
+11.47%
968.00
+1.47%
954.00
+23.58%
772.00
Long Term Provisions
7.00
+16.67%
6.00
+0.00%
6.00
+0.00%
6.00
Non Current Pension And Other Postretirement Benefit Plans
608.00
+8.57%
560.00
+2.94%
544.00
+10.57%
492.00
Tradeand Other Payables Non Current
3,231.00
-5.66%
3,425.00
-9.44%
3,782.00
-16.84%
4,548.00
Non Current Deferred Liabilities
231.00
-0.43%
232.00
-6.83%
249.00
+12.67%
221.00
Non Current Deferred Revenue
231.00
-0.43%
232.00
-6.83%
249.00
+12.67%
221.00
Other Non Current Liabilities
184.00
-14.02%
214.00
-6.14%
228.00
-12.64%
261.00
Stockholders Equity
52,534.00
+6.04%
49,543.00
-7.37%
53,486.00
+6.80%
50,082.00
Common Stock Equity
52,534.00
+6.04%
49,543.00
-7.37%
53,486.00
+10.48%
48,414.00
Capital Stock
9.00
+0.00%
9.00
+0.00%
9.00
-99.46%
1,677.00
Common Stock
9.00
+0.00%
9.00
+0.00%
9.00
+0.00%
9.00
Preferred Stock
—
0.00
0.00
-100.00%
1,668.00
Share Issued
886.90
+0.29%
884.30
+0.43%
880.50
+1.29%
869.30
Ordinary Shares Number
706.90
-1.70%
719.10
-2.72%
739.20
+1.50%
728.30
Treasury Shares Number
180.00
+8.96%
165.20
+16.91%
141.30
+0.21%
141.00
Additional Paid In Capital
17,194.00
+2.79%
16,727.00
+3.44%
16,170.00
+33.95%
12,072.00
Retained Earnings
46,891.00
+6.12%
44,188.00
+7.58%
41,074.00
+4.77%
39,205.00
Gains Losses Not Affecting Retained Earnings
-207.00
+93.57%
-3,218.00
-84.10%
-1,748.00
+39.14%
-2,872.00
Treasury Stock
11,353.00
+39.08%
8,163.00
+304.31%
2,019.00
—
Minority Interest
7.00
+0.00%
7.00
+75.00%
4.00
-50.00%
8.00
Other Equity Adjustments
-207.00
+93.57%
-3,218.00
-84.10%
-1,748.00
+39.14%
-2,872.00
Total Equity Gross Minority Interest
52,541.00
+6.04%
49,550.00
-7.37%
53,490.00
+6.79%
50,090.00
Total Capitalization
70,950.00
+9.08%
65,043.00
-7.34%
70,193.00
+1.48%
69,168.00
Working Capital
5,949.00
+120.41%
2,699.00
-52.34%
5,663.00
-24.43%
7,494.00
Invested Capital
70,952.00
+8.24%
65,548.00
-8.82%
71,888.00
+5.58%
68,091.00
Total Debt
19,696.00
+14.87%
17,146.00
-12.23%
19,536.00
-5.24%
20,616.00
Net Debt
13,803.00
-0.89%
13,927.00
+11.08%
12,538.00
-8.36%
13,682.00
Capital Lease Obligations
1,278.00
+12.01%
1,141.00
+0.62%
1,134.00
+20.77%
939.00
Net Tangible Assets
-8,434.00
+11.43%
-9,522.00
-7.37%
-8,868.00
-26.41%
-7,015.00
Tangible Book Value
-8,434.00
+11.43%
-9,522.00
-7.37%
-8,868.00
-2.13%
-8,683.00
Current Provisions
187.00
+1.08%
185.00
+19.35%
155.00
-9.36%
171.00
Derivative Product Liabilities
0.00
0.00
—
—
Preferred Shares Number
—
1.72
+0.00%
1.72
+0.00%
1.72
Preferred Stock Equity
—
—
—
1,668.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
6,416.00
-4.07%
6,688.00
-6.64%
7,164.00
-15.91%
8,519.00
Cash Flow From Continuing Operating Activities
6,416.00
-4.07%
6,688.00
+3.05%
6,490.00
-14.75%
7,613.00
Cash From Discontinued Operating Activities
0.00
0.00
-100.00%
674.00
-25.61%
906.00
Net Income From Continuing Operations
3,600.00
-7.67%
3,899.00
-7.63%
4,221.00
-33.30%
6,328.00
Depreciation Amortization Depletion
2,447.00
+4.04%
2,352.00
+8.59%
2,166.00
+1.59%
2,132.00
Depreciation
750.00
+4.02%
721.00
+6.81%
675.00
-3.30%
698.00
Amortization Cash Flow
1,697.00
+4.05%
1,631.00
+9.39%
1,491.00
+3.97%
1,434.00
Depreciation And Amortization
2,447.00
+4.04%
2,352.00
+8.59%
2,166.00
+1.59%
2,132.00
Amortization Of Intangibles
1,697.00
+4.05%
1,631.00
+9.39%
1,491.00
+3.97%
1,434.00
Other Non Cash Items
—
25.00
+212.50%
8.00
—
Stock Based Compensation
298.00
+3.47%
288.00
-5.88%
306.00
+3.73%
295.00
Asset Impairment Charge
562.00
+112.08%
265.00
+244.16%
77.00
0.00
Operating Gains Losses
228.00
+300.00%
57.00
-68.68%
182.00
-32.84%
271.00
Gain Loss On Investment Securities
228.00
+300.00%
57.00
-68.68%
182.00
-32.84%
271.00
Change In Working Capital
-719.00
-263.13%
-198.00
+57.87%
-470.00
+66.74%
-1,413.00
Change In Receivables
-216.00
-165.26%
331.00
+2.80%
322.00
+182.78%
-389.00
Changes In Account Receivables
-216.00
-165.26%
331.00
+2.80%
322.00
+182.78%
-389.00
Change In Inventory
-58.00
-139.46%
147.00
-20.54%
185.00
+141.29%
-448.00
Change In Prepaid Assets
-55.00
-120.07%
274.00
-34.61%
419.00
+673.97%
-73.00
Change In Payables And Accrued Expense
50.00
+110.71%
-467.00
-143.23%
-192.00
-343.04%
79.00
Change In Accrued Expense
41.00
+108.44%
-486.00
-1030.23%
-43.00
-144.33%
97.00
Change In Payable
9.00
-52.63%
19.00
+112.75%
-149.00
-727.78%
-18.00
Change In Account Payable
9.00
-52.63%
19.00
+112.75%
-149.00
-727.78%
-18.00
Change In Other Working Capital
-440.00
+8.90%
-483.00
+59.88%
-1,204.00
-106.87%
-582.00
Investing Cash Flow
-1,196.00
+39.63%
-1,981.00
+72.02%
-7,081.00
-216.97%
-2,234.00
Cash Flow From Continuing Investing Activities
-1,196.00
+39.63%
-1,981.00
+71.89%
-7,048.00
-228.58%
-2,145.00
Cash From Discontinued Investing Activities
0.00
0.00
+100.00%
-33.00
+62.92%
-89.00
Net PPE Purchase And Sale
-1,123.00
+18.56%
-1,379.00
-0.58%
-1,371.00
-23.62%
-1,109.00
Purchase Of PPE
-1,156.00
+16.95%
-1,392.00
-0.65%
-1,383.00
-23.70%
-1,118.00
Sale Of PPE
33.00
+153.85%
13.00
+8.33%
12.00
+33.33%
9.00
Capital Expenditure
-1,156.00
+16.95%
-1,392.00
-0.65%
-1,383.00
-23.70%
-1,118.00
Net Investment Purchase And Sale
-115.00
-47.44%
-78.00
+29.73%
-111.00
+78.02%
-505.00
Purchase Of Investment
-127.00
+61.63%
-331.00
-92.44%
-172.00
+67.11%
-523.00
Sale Of Investment
12.00
-95.26%
253.00
+314.75%
61.00
+238.89%
18.00
Net Business Purchase And Sale
9.00
+101.61%
-558.00
+90.05%
-5,610.00
-863.92%
-582.00
Purchase Of Business
0.00
+100.00%
-558.00
+90.05%
-5,610.00
-863.92%
-582.00
Gain Loss On Sale Of Business
—
—
182.00
-32.84%
271.00
Net Other Investing Changes
33.00
-2.94%
34.00
-22.73%
44.00
-13.73%
51.00
Financing Cash Flow
-2,961.00
+64.69%
-8,385.00
-2971.43%
-273.00
+89.38%
-2,570.00
Cash Flow From Continuing Financing Activities
-2,961.00
+64.69%
-8,385.00
-2971.43%
-273.00
+89.38%
-2,570.00
Net Issuance Payments Of Debt
1,045.00
+162.61%
-1,669.00
-2.64%
-1,626.00
+3.67%
-1,688.00
Issuance Of Debt
1,556.00
0.00
0.00
0.00
Repayment Of Debt
-500.00
+70.13%
-1,674.00
-170.00%
-620.00
+35.75%
-965.00
Long Term Debt Issuance
1,556.00
0.00
0.00
0.00
Long Term Debt Payments
-500.00
+70.13%
-1,674.00
-170.00%
-620.00
+35.75%
-965.00
Net Long Term Debt Issuance
1,056.00
+163.08%
-1,674.00
-170.00%
-620.00
+35.75%
-965.00
Net Short Term Debt Issuance
-11.00
-320.00%
5.00
+100.50%
-1,006.00
-39.14%
-723.00
Net Common Stock Issuance
-3,003.00
+48.38%
-5,817.00
-8654.41%
68.00
+119.35%
31.00
Common Stock Payments
-3,088.00
+48.35%
-5,979.00
0.00
0.00
Cash Dividends Paid
-878.00
-14.32%
-768.00
+38.46%
-1,248.00
-52.57%
-818.00
Repurchase Of Capital Stock
-3,088.00
+48.35%
-5,979.00
0.00
0.00
Net Other Financing Charges
-125.00
+4.58%
-131.00
-105.17%
2,533.00
+2766.32%
-95.00
Changes In Cash
2,259.00
+161.42%
-3,678.00
-1835.79%
-190.00
-105.11%
3,715.00
Effect Of Exchange Rate Changes
278.00
+357.41%
-108.00
-283.05%
59.00
+119.28%
-306.00
Beginning Cash Position
2,078.00
-64.56%
5,864.00
-2.19%
5,995.00
+131.83%
2,586.00
End Cash Position
4,615.00
+122.09%
2,078.00
-64.56%
5,864.00
-2.19%
5,995.00
Free Cash Flow
5,260.00
-0.68%
5,296.00
-8.39%
5,781.00
-21.89%
7,401.00
Common Stock Issuance
85.00
-47.53%
162.00
+138.24%
68.00
+119.35%
31.00
Issuance Of Capital Stock
85.00
-47.53%
162.00
+138.24%
68.00
+119.35%
31.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
Sale Of Business
9.00
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category